Guangzhou Baiyunshan Pharmaceutical General Factory And Baiyunshan Qiaoguang Complete Merger
This article was originally published in PharmAsia News
Following their official merger last July, Guangdong's largest antibiotics producer Guangzhou Baiyunshan Pharmaceutical General Factory has successfully integrated with Guangzhou Baiyunshan Qiaoguang Pharmaceutical and the merged entity has begun its new operations. The two companies will complement each other's resources in sales, products and human talent for better development and expanded production capacity. The consolidation will meet the requirements of large-scale, low-cost and flexible production of multiple products. (Click here for more - Chinese Language)
You may also be interested in...
TransEnterix hires Shameze Rampertab as its new CFO and said it expects “modest growth” in Q3 and Q4.
Keeping Track: Viltepso Earns Priority Review Voucher; Manufacturing Trips Fennec; Eagle Drops Ryanodex Exertional Heat Stroke Bid
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
CureVac raised hundreds of millions of dollars this year before its $213m initial public offering as its mRNA vaccine technology moved into the COVID-19 spotlight. Its stock price tripled on its debut.